Anorexia, Hypertension, Pneumothorax, and Hypothyroidism: Potential Signs of Improved Clinical Outcome Following Apatinib in Advanced Osteosarcoma

AIM: Apatinib, a specific tyrosine kinase inhibitor (TKI) that targets mainly vascular endothelial growth factor receptor-2 (VEGFR-2) as well as Ret, c-Kit and c-Src, has been assessed in patients with advanced osteosarcoma (phase II), the primary report of which has been published in PMID 30559126....

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Lu, Xu, Jie, Sun, Xin, Tang, Xiaodong, Yan, Taiqiang, Yang, Rongli, Guo, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956393/
https://www.ncbi.nlm.nih.gov/pubmed/32021426
http://dx.doi.org/10.2147/CMAR.S232823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6956393/
https://www.ncbi.nlm.nih.gov/pubmed/32021426
http://dx.doi.org/10.2147/CMAR.S232823

Ejemplares similares